Deliberately damaging DNA could boost the effectiveness of immunotherapy in kidney cancer 20 Sep 2022 DNA damage is one of the foundational causes of cancer. But researchers have now found that deliberately causing DNA damage – by delivering additional treatments like radiotherapy – could improve the effectiveness of immunotherapy for some people with kidney cancer. Find out more Show/Hide
Common genetic mutation allows cancer cells to gain extra chromosomes which help them survive 09 May 2022 Scientists have found a genetic mutation that results in cancer cells being able to tolerate having an abnormal number of chromosomes – a condition which normally kills cells – allowing them to adapt to their environment and continue to grow. Find out more Show/Hide
Cancer researchers work through night as pandemic restricts access to labs 18 Apr 2021 The number of scientists able to access labs dropped by almost 30 per cent when the latest coronavirus lockdown was announced, according to new data released by the ICR. Some 28% are therefore resorting to working in unsociable hours to keep their research going. The ICR is calling for financial support to avert a two-year delay in cancer research advances reaching patients. Find out more Show/Hide
ICR Discovery Club explores how exploiting cancer’s DNA weaknesses can unlock new treatment 04 Mar 2021
New Athena SWAN Silver Award recognises ICR’s work on diversity and access to opportunities 10 Oct 2019